000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Brain Tumor · Cancer
Bethesda, United States
Clinical Trials Live
Explore public ClinicalTrials.gov records by country, condition, phase and recruitment status. Find a study, review its eligibility criteria, and connect with the listed research team.
Registry counts refresh hourly when this page is visited.
Public records · ClinicalTrials.gov · recently updated first
Brain Tumor · Cancer
Bethesda, United States
Tuberculosis
Gaborone, Botswana; Molepolole, Botswana; Port-au-Prince, Haiti +7 more
Myelodysplastic Syndromes
Bethesda, United States
Non-Small Cell Lung Cancer, NSCLC · KRAS, NRAS, HRAS-mutated NSCLC · KRAS G12C-mutated Solid Tumors, Lung Cancer · Lung Cancer Stage IV, Advanced Solid Tumor, Cancer · RAS G12D-mutated NSCLC
Gilbert, United States; Duarte, United States; Irvine, United States +78 more
Lung Transplantation
Stanford, United States; Baltimore, United States; Salt Lake City, United States +1 more
Opioid Use Disorder (OUD)
Philadelphia, United States
HNSCC,Larynx, Pharynx and Oral Cavity · Squamous Cell Carcinoma · Head and Neck Cancer · Head and Neck Surgery
Nashville, United States
Primary Hyperoxaluria Type 1 (PH1)
Rochester, United States; Saint Paul, United States; Lyon, France +4 more
NAD+ Metabolism · Pharmacokinetics · Bioavailability · Healthy Adults
Guelph, Canada
Advanced Solid Tumor · Metastatic Solid Tumor · Cervical Cancer · Urothelial Carcinoma · Clear Cell Renal Cell Cancer (ccRCC) · Squamous Cell Non Small Cell Lung Cancer
New York, United States; Huntersville, United States; Seoul, South Korea +2 more
Healthy Volunteers · Alcohol Use Disorder (AUD)
Bethesda, United States
Alzheimer s Disease · Mild Cognitive Impairment · Healthy
Bethesda, United States
This catalogue includes records registered on ClinicalTrials.gov, including studies outside India. It does not include every study in every national registry. PharmaBharat does not run studies, assess eligibility or enrol participants.